Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 102 (3), 223-241
- https://doi.org/10.1016/j.pharmthera.2004.04.004
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosisAmerican Heart Journal, 1997
- Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunctionAmerican Heart Journal, 1995
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993
- Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunctionKidney International, 1992
- Distribution and characterization of immunoreactive porcine C-type natriuretic peptideBiochemical and Biophysical Research Communications, 1991
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Atrial Natriuretic Hormone, the Renin–Aldosterone Axis, and Blood Pressure–Electrolyte HomeostasisNew England Journal of Medicine, 1985
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981